THE FUTURE OF NON-INVASIVE RESPIRATORY MONITORING
01
No tubes. No wires.
Non-invasively monitors patient’s breathing, gives reliable alerts for deteriorating volumes, apnea and obstructive breathing
02
Cost-effective
Monitors breathing at a fraction of the cost of existing monitoring technologies by utilizing off-the-shelf hardware.
03
Intuitive & Simple
Straight-forward to use and interpret by all medical staff. Output consists of standard respiratory parameters.
MEET BREATHEVISION
OUR STORY
BreatheVision was founded in 2013 on the need to develop a simple method for early detection of breathing deterioration in patients under conscious sedation... The founders built on their expertise in machine vision and missile navigation algorithms to invent a way to quantify breathing through analyzing chest micro-movements based on low-cost off the shelf hardware.
OUR VISION
To improve patient safety by monitoring essential breathing parameters through machine learning technology and providing immediate warning.
OUR PRODUCT
Our first product, the SafeSed monitoring system, was developed for medical staff to continuously monitor respiration during sedation procedures, such as colonoscopy.
OUR
TEAM
Menashe Terem, MA
CEO
Former executive at El-Al Airlines who also led several medical device companies into OTC and professional markets worldwide.
Ditza Auerbach, PhD
CTO
Physicist experienced in leading imaging and machine learning R&D at Aspect Imaging and Applied Materials.
Yulia Krasilshchikov, MSc
Algorithm developer
Vastly experienced in developing biomedical signals processing and diagnostic algorithms for medical device companies.
Prof. Ilan Shimshoni
Scientific Advisor
Professor of Information Systems at the Computer Science Department at Technion, University of Haifa (Israel)
PROSPECTIVE TARGET MARKETS
Endoscopy
procedural
sedation
MEDICAL NEED
Adverse events associated with sedation
“Drug-induced respiratory depression is the primary cause of morbidity associated with sedation and analgesia”
American Society of Gastroenterology Nurses and Associates 2016
Continuous respiratory monitoring
"…hospitals are expected to address monitoring for …respiratory
depression related to opioids for post-operative patients…. monitoring of ventilation may warrant … to assess breathing"
Centers for Medicare & Medicaid Services (CMS), 2014
Apnea
Obstructive
Shallow
SafeSed- No Tubes, No Wires
Simply Brilliant!
CLINICAL VALIDATION
BreatheVision performs clinical validation of the SafeSed monitoring system at Meir Medical Center (Kfar Saba, Israel). The clinical trial will evaluate safety and performance of the SafeSed system for monitoring patients undergoing elective gastrointestinal endoscopy.
The SafeSed system will be compared with conventional methods of respiratory monitoring - capnography and pulse oximetry.
Patient enrollment to the trial will start in November 2016.
For more information
SafeSed signal vs. capnograph signal
OUR NEWS
2016
1st clinical trial for SafeSed in the Gastro clinic began recruiting at Meir Medical Centre, Israel.
DEC.
2017
1st US Patent granted for the SafeSed system.
OCT.
Successful FDA Pre-Submission meeting for the SafeSed device
APR.
2018
AUG.
2018
Clinical Validation Trial for Volume determination by SafeSed began recruiting at Meir Medical Centre, Israel.
Respiratory rate
(number of breaths in
one minute)
Minute ventilation
(total amount of air inhaled or exhaled in one minute)
Tidal volume
(amount of air moved
with each breath)
Our algorithm analyzes the measured data, alerts on breathing deterioration, and displays continuously the following breathing parameters:
OUR
TECHNOLOGY
